|
|
| | AKOS B024298 Basic information |
| Product Name: | AKOS B024298 | | Synonyms: | ART-CHEM-BB B024298;CHEMBRDG-BB 4013077;AKOS B024298;1-sec-butyl-3-methyl-1H-pyrazol-5-amine(SALTDATA: FREE);1-SEC-BUTYL-3-METHYL-1H-PYRAZOL-5-AMINE;2-SEC-BUTYL-5-METHYL-2H-PYRAZOL-3-YLAMINE;1H-Pyrazol-5-amine, 3-methyl-1-(1-methylpropyl)- | | CAS: | 90206-23-8 | | MF: | C8H15N3 | | MW: | 153.22 | | EINECS: | | | Product Categories: | | | Mol File: | 90206-23-8.mol |  |
| | AKOS B024298 Chemical Properties |
| Melting point | 73-74 °C | | Boiling point | 128-129 °C(Press: 14 Torr) | | density | 1.07±0.1 g/cm3(Predicted) | | pka | 4.68±0.10(Predicted) | | form | solid | | InChI | 1S/C8H15N3/c1-4-7(3)11-8(9)5-6(2)10-11/h5,7H,4,9H2,1-3H3 | | InChIKey | HTSBOHCPDGPFAJ-UHFFFAOYSA-N | | SMILES | NC1=CC(C)=NN1C(C)CC |
| Hazard Codes | T | | Risk Statements | 25 | | Safety Statements | 45 | | RIDADR | UN 2811 6.1 / PGIII | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral |
| | AKOS B024298 Usage And Synthesis |
| | AKOS B024298 Preparation Products And Raw materials |
|
|
Tag:AKOS B024298(90206-23-8)
Related Product Information
|
|
5-(4-Methoxyphenyl)-7-trifluoromethyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid
5-Methyl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
5-Phenyl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
3-Chloro-5-phenyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxylic acid
5-Benzo[1,3]dioxol-5-yl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
1-{[3-Chloro-5-thien-2-yl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-2-yl]carbonyl}-1,2,3,4-tetrahydroquinoline
3-Chloro-N-(4-(1-hydroxyethyl)phenyl)-5-p-tolyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
5-(4-Chlorophenyl)-N-[2-(methylthio)phenyl]-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
3-Chloro-N-cyclohexyl-5-phenyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
N-(4-Ethylphenyl)-5-phenyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
5-Thiophen-2-yl-7-trifluoromethyl-4,5,6,7-tetrahyd ro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
(4-Benzylpiperazin-1-yl)(5-(4-fluorophenyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-2-yl)methanone
3-Bromo-N-(2-furylmethyl)-5-(4-methoxyphenyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
3-Chloro-N-(2-phenylethyl)-5-thien-2-yl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
N,N-Dibenzyl-3-chloro-5-phenyl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
3-Bromo-5-phenyl-7-(trifluoromethyl)-N-[3-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
3-Chloro-5-phenyl-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
2-(Pyrrolidin-1-ylcarbonyl)-5-thien-2-yl-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine
|